Carlo Sistilli - Feb 12, 2025 Form 4 Insider Report for Edesa Biotech, Inc. (EDSA)

Role: Director
Signature: /s/ Stephen Lemieux, Attorney-in-Fact for Carlo Sistilli
Stock symbol: EDSA
Transactions as of: Feb 12, 2025
Transactions value $: $19,999
Form type: 4
Date filed: 2/14/2025, 05:02 PM
Previous filing: Jul 24, 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EDSA	Common Shares	Award	$20K	+10.4K		$1.92	10.4K	Feb 12, 2025	Direct	F1
holding	EDSA	Common Shares						522	Feb 12, 2025	Held by York-Cav Enterprises, Inc.	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On February 12, 2025, the Reporting Person purchased in a private placement, 10,416 common shares, without par value, of the Issuer, for a purchase price of $1.92 per share.
F2	Shares reported reflect a 1-for-7 reverse share split effective October 11, 2023.
F3	York-Cav Enterprises, Inc. is partially owned by the Reporting Person. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Remarks:

Ex. 24 - Power of Attorney